Lexington, MA, United States of America

Rohin Mhatre

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biogen Idec Ma Inc.. Active years: 2012-2013.


% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rohin Mhatre: Innovator in Cyclodextrin Detection

Introduction

Rohin Mhatre is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceutical preparations, particularly in the detection and quantitation of cyclodextrins. With a total of 2 patents to his name, Mhatre's work is pivotal in enhancing the understanding and evaluation of cyclodextrins in various solutions.

Latest Patents

Mhatre's latest patents focus on the detection and quantitation of cyclodextrins and cyclodextrin derivatives in solutions that contain proteins. These inventions provide methods for evaluating pharmaceutical preparations for the presence of residual cyclodextrins, which is crucial for ensuring the safety and efficacy of drug formulations.

Career Highlights

Rohin Mhatre is currently employed at Biogen Idec MA Inc., where he applies his expertise in the field of biopharmaceuticals. His work at Biogen Idec has allowed him to collaborate with leading professionals in the industry, further advancing the research and development of innovative solutions.

Collaborations

Some of Mhatre's notable coworkers include Zoran Sosic and Rulin Qian. Their collaborative efforts contribute to the ongoing advancements in the detection and quantitation of cyclodextrins, enhancing the overall impact of their research.

Conclusion

Rohin Mhatre's contributions to the field of cyclodextrin detection are invaluable. His patents and work at Biogen Idec MA Inc. reflect his commitment to innovation in pharmaceutical preparations. Mhatre's ongoing research continues to pave the way for advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…